Skip to content

The effect of Curcumin supplementation on mortality rate and clinical status in patients with trauma

Investigating the effect of Curcumin supplementation on mortality rate and clinical status in patients with trauma hospitalized in the intensive care unit

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20130829014521N21
Enrollment
327
Registered
2023-04-23
Start date
2023-03-21
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Trauma. -

Interventions

Intervention 1: Intervention group 1: Curcumin tablet twice daily (each tablet contain 500 mg Curcumin plus 5mg Piperine made by Sami-Sabinsa Group Limited) for 7 days. Intervention 2: Intervention gr

Sponsors

Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to No maximum

Inclusion criteria

Inclusion criteria: Minimum age of 12 years old ICU admission due to trauma Sign informed consent by the patients or his legal guardian Oral or enteral nutrition (nasogastric or orogastric tube)

Exclusion criteria

Exclusion criteria: Pregnancy or breast feeding Severe and active bleeding Re-hospitalization or refer from other hospitals or ICUs History of obstructive biliary disorders Allergy to Turmeric

Design outcomes

Primary

MeasureTime frame
Mortality during the intervention in the ICU (8-day ICU mortality). Timepoint: During the first 8-day ICU stay. Method of measurement: Observation and record in checklist.;60-days mortality. Timepoint: Mortality during the 60 days after entering to the study. Method of measurement: The information will be obtained by phone call.;30-days mortality. Timepoint: Mortality during the 30 days after entering to the study. Method of measurement: The information will be obtained by phone call.

Secondary

MeasureTime frame
120-day mortality. Timepoint: Mortality during the 120 days after entering to the study. Method of measurement: The information will be obtained by phone call.;180-day mortality. Timepoint: Mortality during the 180 days after entering to the study. Method of measurement: The information will be obtained by phone call.;Duration of hospitalization. Timepoint: Duration of hospitalization will be recorded at the end of the study period. Method of measurement: Observation (record in checklist).;Duration of mechanical ventilation. Timepoint: Duration of mechanical ventilation will be recorded at the end of the intervention period. Method of measurement: Observation (record in checklist).;GCS (Glascow coma scale). Timepoint: Before and after the intervention period (7 days). Method of measurement: Summing the scores of eye opening, verbal response and motor response.;APACHE II(Acute Physiology and Chronic Health Evaluation). Timepoint: Before and after the intervention (7 days). Method of measurement: According to scoring system (APACHE is a severity-of-disease classification system that estimates mortality based on a number of laboratory values and patient signs taking both acute and chronic disease into account. This score will be calculated based on the guidelines and recorded in the checklist).;SOFA (Sequential Organ Failure Assessment). Timepoint: Before and after the intervention (7 days). Method of measurement: According to scoring system (SOFA score is a scoring system that assesses the performance of several organ systems in the body).;Modified nutrition risk in critically ill (mNUTRIC) score. Timepoint: Before and after the intervention (7 days). Method of measurement: According to scoring system (mNUTRIC is used to assess the nutrition risk in critically ill patients. This score estimates the risk according to some variables such as age, the number of comorbidities, hospitalization days, etc. This score will be calculated based on the guidelines and recorded in

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAmihossein Sahebkar

Mashhad University of Medical Sciences

sahebkara@mums.ac.ir0098513180110

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Jun 11, 2026